We were informed that Ge Fiona Gao received the Best Abstract Award for the AAPS Annual Meeting 2019 with her abstract “Elucidating Human Pharmacokinetics of a Subcutaneous Microparticle Depot Formulation: Impact of Drug Formulation, Patient Population and Clinical Setting“. We are proud to have her in our team and wish her a successful visit at the conference in San Antonio, Texas!
Our new article on the challenges associated with market translation of nanotechnology-related products has been accepted by Advanced Drug Delivery Reviews.
The international team of experts has done a great job in providing their expertise. Thanks to you Margareth Marques (USP), Choo Qiuyi (HSA), Mukul Ashtikar (Fraunhofer IME), Thais Correa Rocha (ANVISA) and Susanne Bremer-Hoffmann (EC-JRC).
About the position
A PhD-student position within the field of nanomedicine is available in the Wacker Research Lab at the Department of Pharmacy of the National University of Singapore. Together with several partners from academia and the pharmaceutical industry, the candidate will work in an interdisciplinary translational research project developing high-end in vitro assays to predict the in vivo performance of nanotherapeutics for the subcutaneous route of administration.
About the research project
Today, many new compounds are characterized by low peroral bioavailability as well as a short plasma half-life. In particular, the rapidly growing market of biopharmaceuticals has been addressed by the development of microparticle and nanoparticle formulations acting as a depot in the interstitial fluid. Although the physiology of the subcutaneous tissue is known, the intertwined kinetic processes which influence pharmacokinetics of the drug have only insufficiently been investigated. Aim of this project is the development of novel formulations of peptides and proteins which resist the physiological environment and can be released into the blood. To test these formulations a novel in vitro release and diffusion assay in combination with physiologically-based pharmacokinetic modeling will be utilized.
Requirements and conditions
The PhD-position’s main objective is to qualify for work in research positions. Admission criteria of the National University of Singapore (including an interview) and the scholarship program must be met.
General admission criteria of research-based programs
Conditions of the NUS scholarship
Qualifications
What matters for us?
In the evaluation of which candidate is best qualified, emphasis will be placed on education, experience and personal suitability, as well as motivation, in terms of the qualification requirements specified in the advertisement
For further information please contact applications@nanomedicines.de including a cover letter, CV and other relevant information (certificates etc.).
Just a few days ago I was invited to join the Editorial Board of the European Journal of Pharmaceutics and Biopharmaceutics. It is a great honor and I am looking forward to the new challenges.
Thanks to the Editor-in-Chief Prof. Dr. Achim Göpferich and all other editors for putting trust in me!
For the next term from 2020 to 2025 I will join the USP Expert Panel on New Advancements in Product Performance Testing. A workshop will take place in December 2019 to share our latest experiences with novel drug release methods. Please check the USP website for further information…
I am pleased to present our latest research at the Malvern Panalytical workshop in Singapore. I will talk about the importance of characterization method for biomedical research and how it affects our successes in drug delivery…
Our latest research will be presented at the 3rd European Conference on Pharmaceutics in Bologna. Together with partners from Hungary, Israel, and Sweden we developed a novel brain delivery system to deliver NGF to the brain. I deliver a talk at the conference…
Viva Italia!
Matthias G. Wacker is guest editor of the thematic issue ‘Frontiers in pharmaceutical nanotechnology‘ which is dedicated to Prof. Jörg Kreuter, Goethe University. Prof. Kreuter’s research has shed new light on the interactions of nanocarrier devices with the blood brain barrier pointing to a new era of drug delivery.
In February 2019, I will start my new position at the National University of Singapore. The university is a great place doing outstanding drug delivery research. I will support the Department of Pharmacy.
